Steve Schain

May 02, 2019 | The Legal Intelligencer

With the FDA "locked and loaded," and billions of annual sales and "deal flow capital" hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims.

By Steve Schain

10 minute read

March 25, 2019 | The Legal Intelligencer

Envision managing the risk of a volatile, staggeringly lucrative, 100-percent federally legal enterprise? Toss in ridiculously inconsistent federal, state and local regulations, insanely evolving technologies and efficiencies and an industrywide disinclination to ever "play by the rules."

By Steve Schain

8 minute read

January 17, 2019 | The Legal Intelligencer

Derived from identical plants, vastly easier to cultivate, and profoundly more profitable, industrial hemp always lacked legalized marijuana's sizzle.

By Steve Schain

8 minute read

August 31, 2018 | The Legal Intelligencer

With Corona brewer and Robert Mondavi wine producer Constellation Brands Inc. investing $3.88 billion in grower Canopy Growth Corp. and the Wall Street Journal estimating 2018 U.S. legal marijuana sales at $10.2 billion, the writing's on the wall: cannabis is big business and ripe for the plucking by the plaintiffs bar.

By Steve Schain

7 minute read

February 05, 2018 | New Jersey Law Journal

Marijuana related businesses face staggering safety, security and operational issues.

By Steve Schain

9 minute read

January 19, 2018 | The Legal Intelligencer

Is U.S. Attorney General Jeff Sessions threatening to single-handedly crush the $7.2 billion legalized marijuana industry spanning 30 states, generating millions in taxes and providing tens of thousands of jobs?

By Steve Schain

7 minute read